Groundbreaking research at Seattle Children’s Hospital provides critical genetic diagnoses for newborns within 48 hours.
SEATTLE — When Cayden Chambers was born seven weeks premature in July of 2022, his parents, Mairin Jameson and Trystan Chambers, expected minor challenges related to his early arrival and kidney issues. What they didn’t anticipate was learning their son had a rare genetic condition before he was two weeks old.
That swift diagnosis came through SeqFirst, a first-of-its-kind study at Seattle Children’s Hospital that is revolutionizing genetic testing for NICU newborns. The research has tested 4,000 babies in the NICU and found that about one in three have an underlying
→ Continue reading at King 5
